| Date | Title | | | 03/18/10 | Nanosphere Verigene(R) SP Respiratory Virus Panel Categorized as Moderate Complexity by FDA| NORTHBROOK, Ill., Mar 18, 2010 (GlobeNewswire via COMTEX) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
The "Moderate Complexity" designation allows the... |
|  | | 03/04/10 | Massachusetts Institute of Technology's Technology Review Names Nanosphere One of World's Most Innovative Companies| NORTHBROOK, Ill., Mar 4, 2010 (GlobeNewswire via COMTEX) -- Nanosphere, Inc., (Nasdaq:NSPH), announced today it was selected one of the world's most innovative companies by Massachusetts Institute of Technology's Technology Review with its inclusion on the 2010 TR50 list.
The 2010 TR50 is Technology Review's first annual list identifying companies that demonstrate the most impressive and noteworthy innovations occurring in technology.
"In choosing the TR50, we picked companies with this year... |
| | | 03/04/10 | Nanosphere, Inc. to Present at the 2010 Cowen Health Care Conference| NORTHBROOK, Ill., Mar 4, 2010 (GlobeNewswire via COMTEX) -- Nanosphere, Inc., (Nasdaq:NSPH), announced that the company will present at the 30th Annual Cowen & Company Health Care Conference taking place at the Boston Marriott Copley Place in Boston, Massachusetts from March 8 to 11, 2010. William Moffitt, Nanosphere's president and chief executive officer, will present at 1:30 P.M. Eastern Standard Time on Tuesday, March 9, 2010.
The webcast, along with presentation slides, can be accessed... |
| | | 02/24/10 | Nanosphere Announces Fourth Quarter 2009 Results| NORTHBROOK, Ill., Feb 24, 2010 (GlobeNewswire via COMTEX) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial results for the fourth quarter and year ended December 31, 2009.
Revenues for full year of 2009 were $2.2 million compared to $1.4 million for 2008. Product sales were $1.1 million for fiscal 2009 as compared to $1.0 million for fiscal 2008. Fiscal 2009 revenues included $1.0 million of... |
| | | 02/08/10 | Nanosphere to Report Fourth Quarter and Year-End 2009 Results and Hold Investor Call Wednesday, February 24, 2010| NORTHBROOK, Ill., Feb 8, 2010 (GlobeNewswire via COMTEX) -- Nanosphere, Inc., (Nasdaq:NSPH), which develops, manufactures, and markets advanced molecular diagnostics systems, will report its results for the fourth quarter and full year of 2009 after market close on Wednesday, February 24, 2010. The company will also hold a live investor conference call and webcast at 5:00 P.M., Eastern Time.
The teleconference can be accessed by dialing 888.713.4214 (U.S./Canada) or 617.213.4866 (internationa... |
| |
|
